|
|
||||||||
Eur J Cardiothorac Surg 1999;16:218-221
© 1999 Elsevier Science NL
Division of Cardiac Surgery, University of Verona Medical School, OCM Borgo Trento, Piazzale Stefani 1, 37126 Verona, Italy
Corresponding author. Tel.: +39-45-8072476; fax: +39-45-8073308
e-mail: fsant{at}yahoo.com,
| Abstract |
|---|
|
|
|---|
Key Words: Left atrial line Pressures monitoring Pulmonary vascular constriction Open heart operations Postoperative care
| 1. Introduction |
|---|
|
|
|---|
Despite the widespread utilization of left atrial catheters after cardiac surgery in the last decade, concerns still remain about their routine use due to the reported risks of hemorrhage following catheter removal [1,2], mechanical interference of the line with valve prosthesis in the mitral position [4], systemic gaseous microemboli during left atrial catheter insertion [5], and retained catheter fragments [6].
Several techniques have been reported to minimize the possible risks associated with left atrial catheter use [713], but a word of caution has also been spent to confine its utilization only to selected cases in order to lessen the potential sequelae. Selected use of left atrial lines has also become less common since surgeons acquired confidence in the safety and reliability of pulmonary artery catheters, whose use however, is not totally risk-free either [1422]. Furthermore, the cost of this device routinely utilized in a large volume practice should not be underestimated [15].
In order to assess the risk/benefit ratio including cost, associated with the procedure, the experience with the routine use of left atrial monitoring lines after cardiac surgery at a tertiary care university hospital over the last 7 years was critically reviewed. The purpose of this study is to propose a rationale scheme for their continued use.
| 2. Material and methods |
|---|
|
|
|---|
The institutional procedure for the placement and maintenance of the left atrial catheter as well as for its removal, was reviewed over this seven years period. In all instances, a 16-gauge radiopaque polyethylene catheter (19-gauge in patients below 15 kg body weight) (Becton Dickinson Vascular Access, Sandy, UT, USA) was inserted through a blade hole in the center of a 3-0 Prolene (Ethicon Inc., Somerville, NJ) non-pledgeted suture (5-0 Prolene in patients below 15 kg of body weight). The site of insertion was located not on the right superior pulmonary vein directly as reported by others [10], but rather anteriorly, in the groove developed between the posterior right and anterior left atrial walls (Sondegard groove) (Fig. 1a), caring to recruit with the suture line all the soft tissue around the site of puncture for hemostatic purposes (Fig. 1b). Before line insertion, the same site was routinely used for left ventricular venting during the surgical procedure.
|
The catheter line was always inserted filled up with saline solution to minimized the risk of gaseous microemboli. The procedure was always accomplished when still on cardiopulmonary by-pass, under no ventilation and inserting the catheter into a filled heart in order to prevent the entrainment of gaseous microemboli of particular importance in patients with low left-sided filling pressure [5]. The left atrial line was routinely attached to a pressure transducer in the operating room to guide during weaning from cardiopulmonary bypass. Freedom to move the catheter relative to the myocardial tissue as well as its function, and the position of the line itself, was always manually confirmed before chest closure. Upon arrival in the Intensive Care Unit (ICU) the left atrial line was aspirated and attached to a transducer to monitor pressure continuously. A heparin flush (1000 units of heparin added to 500 ml of Ringer's lactate) was then maintained at a flow rate of 3 ml/h. The position of the catheter tip was confirmed by chest roentgenogram before clinical assessment were made and therapeutic modalities initiated. The catheters remained sutured to the skin during their period of utility in the ICU. Almost all catheters were removed on the first or second postoperative day before chest tube removal. In no cases the duration of monitoring with a left atrial catheter was prolonged beyond 72 h since insertion. All non-functioning catheters were promptly removed at any stage during the postoperative period. In patients requiring additional hemodynamic information and/or an expected prolonged period of hemodynamic monitoring (>72 h), the line was removed and switched to a Swan-Ganz catheter. High left atrial pressure and/or abnormal coagulation values have not been considered contra-indications for catheter removal in our experience.
The use of this scheme was found to be consistent over the 7 years to which this analysis refers.
For the purpose of this study, the registry of all perioperative complications in the patients operated upon between November 1991 and June 1998, was reviewed and all the sequelae related to insertion, management, and removal of a left atrial catheter were noted.
| 3. Results |
|---|
|
|
|---|
In our series, a subgroup of 385 patients (6%) were switched to a Swan-Ganz catheter in the postoperative period in order to acquire additional hemodynamic information or in view of a long expected period of need for hemodynamic monitoring.
In nine selected patients (0.15%) left atrial lines were used as a preferential route for drugs infusion. The common patient hemodynamic profile was that of a diminished left ventricular contractility and increased right ventricular afterload, related to increased pulmonary vascular resistance. Left atrial catheter administration of epinephrine (associated with prostaglandin E1 infusion into a pulmonary catheter in five cases) improved myocardial performance without increasing right ventricular after-load, as shown by contemporary mean pulmonary artery pressure monitoring.
A total of 14 patients suffered a complication clearly related to the left monitoring line, for an overall complication rate of 0.24%. The complications identified were broken down into two general types: (1) bleeding occurring after catheter removal; (2) catheter retention.
After line removal, correlated bleeding necessitating transfusion occurred in 10 patients, seven of whom required surgical reexploration and suturing of the insertion site, performed emergently in the ICU in one case. In all these cases (none after mitral valve replacement), the cause of bleeding was believed to correlate with a sub-optimal technique utilized for line positioning. Entrapment of the catheter at the time of line removal required surgical revision in four cases with mediastinal reexploration in one case and a less invasive procedure limited to the rectus fascia, performed in the ICU, in three (Table 1).
|
| 4. Discussion |
|---|
|
|
|---|
This tendency has prompted us to analyze retrospectively our experience with left atrial monitoring line routinely used at our institution since 1991.
Our 7-year series, involving more than 5800 left atrial monitoring catheters demonstrates the overall safety of this device, managed according to the rules reported. Intraoperatively, careful preparation of the insertion site (Sondegard groove), meticulous tailoring of the suture purse-string, insertion of a filled-up catheter when still on by-pass under no ventilation into a filled heart, confirmation of its mobility at the insertion site, and appropriate patient closure, all significantly minimized catheter related morbidity. Nursing personnel orientation on the scrupulous management of this lines appears also mandatory to contain complications.
Overall complication rate in our series was 0.24%. Only one patient required reexploration on an emergency basis. Indeed, close monitoring of patients after catheter removal, anticipating of any bleeding complications, with rapid resuscitation if necessary, will further increase the safety of this monitoring method.
Although it is difficult to quantify the data made available by these lines, we have found them extremely useful and have based a myriad of therapeutic decisions and interventions on the information derived from them. Furthermore, in a subgroup of critical patients (0.15%) the left atrial line showed very useful for interventional purposes allowing direct left atrial administration of epinephrine thus providing improvement of myocardial performance with less effect on right ventricular afterload.
All patients showing evidence of gross neurologic dysfunction postoperatively in our series (1.8%), had clear pre- and/or perioperative risk factors for stroke. These data together with a meticulous management of the lines seem to suggest a minimal impact of the procedure on neurological outcome, although routine monitoring of microembolism and sensitive neurologic testing were not performed. Several studies of patients during cardiac surgery however, have shown that relatively large numbers of gaseous microemboli can be entrained into the systemic circulation without causing an adverse neurologic outcome [5,2327]. Further, the number of microemboli entrained by left atrial catheterization and catheter flushing has been shown to be far less than the number caused by routine aortic cannulation and the initiation of left ventricular ejection after bypass [5].
In an era of cost containment and efficient resource utilization the possibility to limit the expense for routine patient monitoring still providing a good quality care should not be underestimated. In this view, left atrial line should be regarded as an intermediate tool, limiting the use of Swan-Ganz catheters only to selected cases.
In conclusion, complications of left atrial monitoring catheters in cardiac surgery do occur but at a very low and acceptable rate. No mortality was correlated to their use in our series. Complication rate can be further lowered by a meticulous management of the device. The wealth of diagnostic and prognostic data and even therapeutic options obtained by this manner seems to outweighs the associated risk. Left atrial line use appears also favorable in term of costs containment compared to other invasive methods to provide information on left ventricular pre-loading. The letter should be limited to selected cases.
| References |
|---|
|
|
|---|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |